METASTATIC PROSTATE CARCINOMA
Clinical trials for METASTATIC PROSTATE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PROSTATE CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC PROSTATE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo for prostate cancer halted early
Disease control TerminatedThis study looked at adding ribociclib to the standard hormone therapy enzalutamide for men with a certain type of advanced prostate cancer that had spread and no longer responded to hormone therapy alone. The goal was to find the best dose and see if the combination could lower …
Matched conditions: METASTATIC PROSTATE CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New PET scan agent aims to map hidden prostate cancer spread
Diagnosis TerminatedThis study tested a new imaging agent called 68Ga-PSMA-11 to see if it could give clearer pictures of where prostate cancer has spread in men with advanced, treatment-resistant disease. The goal was to help doctors better understand the location of tumors. The study was terminate…
Matched conditions: METASTATIC PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: Thomas Hope • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC
-
Can genetic testing help men with metastatic prostate cancer?
Knowledge-focused TerminatedThis study offered genetic testing to men whose prostate cancer has spread to other parts of the body. Participants provided saliva samples to check for inherited mutations in about 30 cancer-risk genes. The goal was to understand how often these mutations occur and how men feel …
Matched conditions: METASTATIC PROSTATE CARCINOMA
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC